Sign Up to like & get
recommendations!
0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-66292-3
Abstract: Cilostazol, a phosphodiesterase 3 inhibitor, reduces the amyloid-beta (Aβ) burden in mouse models of Alzheimer disease by as yet unidentified mechanisms. In the present study, we examined the possibility that cilostazol ameliorates lysosomal dysfunction. Astrocytes…
read more here.
Keywords:
lysosomal reacidification;
cilostazol restores;
zinc;
metallothionein ... See more keywords